
NuVasive NUVA
Quartalsbericht 2023-Q2
hinzugefügt 02.08.2023
NuVasive Abschreibung & Amortisation 2011-2026 | NUVA
Abschreibung & Amortisation Jährlich NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 147 M | 150 M | 141 M | 136 M | 130 M | 121 M | 103 M | 65.9 M | 65.8 M | 63.1 M | 51.9 M | 36.2 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 150 M | 36.2 M | 101 M |
Abschreibung & Amortisation Vierteljährlich NuVasive
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8 M | 33.5 M | - | 110 M | 13.4 M | 36.8 M | - | 112 M | 15.9 M | 36.4 M | - | 106 M | 70.1 M | 35 M | - | 101 M | 67.6 M | 34.1 M | - | 96.4 M | 64.2 M | 32.1 M | - | 88.9 M | 58.7 M | 29.5 M | - | 73.8 M | 46.3 M | 21.2 M | - | 49 M | 32.6 M | 16.1 M | - | 46.5 M | 31 M | 15.4 M | - | 46.3 M | 30.3 M | 14.6 M | - | 38.2 M | 25.3 M | 12.1 M | - | 24.8 M | 15.9 M | 7.78 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 112 M | 7.78 M | 44.7 M |
Abschreibung & Amortisation anderer Aktien in der Medizinische Geräte
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
188 K | - | 37.08 % | $ 85.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
11.7 M | - | - | $ 3.31 B | ||
|
Xtant Medical Holdings
XTNT
|
4.22 M | $ 0.55 | -2.31 % | $ 73.5 M | ||
|
Dynatronics Corporation
DYNT
|
487 K | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
2.78 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
191 K | - | -26.83 % | $ 2.62 M | ||
|
Zimmer Biomet Holdings
ZBH
|
996 M | $ 88.57 | -0.65 % | $ 18 B | ||
|
Allied Healthcare Products
AHPI
|
451 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
77.5 M | $ 10.93 | -5.12 % | $ 1.64 B | ||
|
Conformis
CFMS
|
4.03 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
6.15 M | $ 0.4 | 4.21 % | $ 41.1 M | ||
|
Insulet Corporation
PODD
|
90.4 M | $ 208.22 | -4.53 % | $ 14.6 B | ||
|
Cardiovascular Systems
CSII
|
3.69 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
424 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
1.21 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
289 K | - | -20.74 % | $ 369 K | ||
|
CONMED Corporation
CNMD
|
17.1 M | $ 34.58 | -5.62 % | $ 1.07 B | ||
|
NanoVibronix
NAOV
|
1 K | - | - | $ 1.08 M | ||
|
Cytosorbents Corporation
CTSO
|
1.57 M | $ 0.59 | -1.18 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
340 K | $ 2.15 | -5.29 % | $ 3.36 M | ||
|
Edwards Lifesciences Corporation
EW
|
157 M | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
BIOLASE
BIOL
|
2.8 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
382 M | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
21.1 M | $ 15.52 | -5.08 % | $ 364 M | ||
|
Invacare Corporation
IVC
|
15.5 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
421 K | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
859 K | $ 0.7 | 2.32 % | $ 29.3 M | ||
|
Penumbra
PEN
|
17.5 M | $ 335.1 | -0.39 % | $ 13 B | ||
|
Inspire Medical Systems
INSP
|
14 M | $ 50.13 | -0.63 % | $ 1.47 B | ||
|
Pulmonx Corporation
LUNG
|
1.1 M | $ 1.17 | -5.65 % | $ 47.6 M | ||
|
Cutera
CUTR
|
8.1 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
5.46 M | - | - | $ 10.2 M | ||
|
Nevro Corp.
NVRO
|
7.95 M | - | - | $ 217 M | ||
|
Surgalign Holdings
SRGA
|
2.18 M | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
2.4 M | - | - | $ 6.6 M | ||
|
GBS
GBS
|
970 K | - | -0.57 % | $ 7.12 M | ||
|
AVITA Medical
RCEL
|
2.35 M | $ 3.82 | -1.04 % | $ 106 M | ||
|
AxoGen
AXGN
|
6.66 M | $ 31.28 | -3.01 % | $ 1.44 B |